Improvement of survival in sex cord stromal tumors – an observational study with more than 25 years follow-up

References

• MP Curado, Edwards, B, Shin, HR, Storm, H, Ferlay, J, Heanue, M, , et al. Cancer incidence in five continents. Lyon, IARC scientific publications no. 160. Lyon: IARC Press, 2007.
   Google Scholar
• Ferlay, J, Bray, F, Sankila, R, Parkin, D. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide, version 2.0. Lyon: IARC Press, 2004.
   Google Scholar
• Robert Koch Institut Gesellschaft und die Gesellschaft epidemiologischer Krebsregister in Deutschland e.V. Krebs in Deutschland-Häufigkeiten und Trends. [Cancer in Germany-Incidence and Trends. fifth revised, updated version] (in German.). Berlin: Druckhaus Berlin-mitte GmbH, 2008.
   Google Scholar
• B Schmalfeldt. Maligne Ovarialtumoren – Empfehlungen zur Diagnostik, Therapie und Nachsorge. [Malignant ovarian tumors-recommendations to diagnostics, therapy and aftercare] (in German). Munich: Zuckschwerdt Verlag, 2007.
   Google Scholar
• Engel J, Eckel R, Schubert-Fritschle G, Kerr J, Kuhn W, Diebold J, et al. Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate. Eur J Cancer 2002; 38: 2435–45
   PubMed Web of Science ®Google Scholar
• Auranen A, Sundstrom J, Ijas J, Grenman S. Prognostic factors of ovarian granulosa cell tumor: a study of 35 patients and review of the literature. Int J Gynecol Cancer 2007; 17: 1011–18
   PubMed Web of Science ®Google Scholar
• Zhang M, Cheung MK, Shin JY, Kapp DS, Husain A, Teng NN, et al. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary – an analysis of 376 women. Gynecol Oncol. 2007; 104: 396–400
   PubMed Web of Science ®Google Scholar
• Colombo N, Parma G, Zanagnolo V, Insinga A. Management of ovarian stromal cell tumors. J Clin Oncol. 2007; 25: 2944–51
   PubMed Web of Science ®Google Scholar
• Homesley HD, Bundy BN, Hurteau JA, Roth LM. Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: a Gynecologic Oncology Group study. Gynecol Oncol. 1999; 72: 131–37
   PubMed Web of Science ®Google Scholar
• Pautier P, Lhomme C, Culine S, Duvillard P, Michel G, Bidart JM, et al. Adult granulosa-cell tumor of the ovary: a retrospective study of 45 cases. Int J Gynecol Cancer 1997; 7: 58–65
   PubMed Web of Science ®Google Scholar
• Pecorelli S, Wagenaar HC, Vergote IB, Curran D, Beex LV, Wiltshaw E, et al. Cisplatin (P), vinblastine (V) and bleomycin (B) combination chemotherapy in recurrent or advanced granulosa(-theca) cell tumors of the ovary. An EORTC Gynaecological Cancer Cooperative Group study. Eur J Cancer 1999; 35: 1331–37
   PubMed Web of Science ®Google Scholar
• Chan JK, Zhang M, Kaleb V, Loizzi V, Benjamin J, Vasilev S, et al. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary – a multivariate analysis. Gynecol Oncol. 2005; 96: 204–9
   PubMed Web of Science ®Google Scholar
• Al-Badawi IA, Brasher PM, Ghatage P, Nation JG, Schepansky A, Stuart GC. Postoperative chemotherapy in advanced ovarian granulosa cell tumors. Int J Gynecol Cancer 2002; 12: 119–23
   PubMed Web of Science ®Google Scholar
• Savage P, Constenla D, Fisher C, Shepherd JH, Barton DP, Blake P, et al. Granulosa cell tumors of the ovary: demographics, survival and the management of advanced disease. (The Royal College of Radiologists) Clin Oncol. 1998; 10: 242–5
   PubMedGoogle Scholar
• Ries LA. Ovarian cancer. Survival and treatment differences by age. Cancer 1993; 71: 524–29
   PubMed Web of Science ®Google Scholar
• Gershenson DM, Morris M, Burke TW, Levenback C, Matthews CM, Wharton JT. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin. Obstet Gynecol. 1996; 87: 527–31
   PubMed Web of Science ®Google Scholar
• Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982; 38: 933–42
   PubMed Web of Science ®Google Scholar
• Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. J Clin Oncol. 2003; 21: 1180–9
   PubMed Web of Science ®Google Scholar
• Uygun K, Aydiner A, Saip P, Basaran M, Tas F, Kocak Z, et al. Granulosa cell tumor of the ovary: retrospective analysis of 45 cases. Am J Clin Oncol. 2003; 26: 517–21
   PubMed Web of Science ®Google Scholar
• Chung HH, Hwang SY, Jung KW, Won YJ, Shin HR, Kim JW, et al. Ovarian cancer incidence and survival in Korea: 1993–2002. Int J Gynecol Cancer 2007; 17: 595–600
   PubMed Web of Science ®Google Scholar
• Munich Cancer Registry (MCR). Jahresbericht 1999. Available online at: http://www.tumorregister-muenchen.de, Accessed 15 December 2008.
   Google Scholar